These results are similar to ours, but we further substantiated that FAM99A and FAM99B are tumor suppressors under hypoxic conditions, which further enriches the value of FAM99A and FAM99B as biomarkers in the treatment of HCC. Here, FAM99A is linked to hepatocellular carcinoma.